Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.685 USD | +1.80% | +3.11% | -20.65% |
05-14 | Transcript : NRx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-06 | NRx Pharmaceuticals Shares Rise 38% After Positive Drug Trial Data | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.65% | 37.73M | |
+64.56% | 62.86B | |
-0.96% | 41.38B | |
+45.66% | 40.38B | |
-8.93% | 27.64B | |
+13.09% | 26.46B | |
-22.73% | 18.9B | |
+3.67% | 12.67B | |
+24.99% | 12.27B | |
+28.86% | 12.07B |
- Stock Market
- Equities
- BRPA Stock
- News NRx Pharmaceuticals, Inc.
- NRX Pharmaceuticals Appoints Ira Strassberg as CFO